The Indian pharmaceutical sector showed mixed performance on January 9, 2026, amid a slightly declining broader market. As of approximately 10:20 AM IST, the S&P BSE Healthcare Index stood at 43,985.34, down 0.35%. The S&P BSE Sensex was at 84,105.75, down 0.09%, while the Nifty 50 was at 25,862.70, down 0.05%.

Most major pharma stocks traded flat to lower.

Key Pharma Stocks Prices and Changes (as of ~10:20 AM)

Company NSE Price (₹) NSE Change (%)
Natco Pharma 921.00 +1.24
Dr. Reddy’s Lab 1,210.80 +0.32
Divi’s Laboratories 6,610.00 +0.14
Strides Pharma Science 969.30 +0.13
Biocon 378.30 +0.09
Cipla 1,460.00 -0.04
Aurobindo Pharma 1,204.20 -0.16
J.B. Chemicals 1,904.80 -0.32
Aarti Drugs 391.35 -0.37
Torrent Pharma 4,008.30 -0.45
Lupin 2,180.00 -0.50
Zydus Lifesciences 902.45 -0.56
IPCA Labs 1,535.00 -0.58
Sun Pharma 1,750.00 -0.61
Ajanta Pharma 2,816.90 -0.76
Glenmark Pharma 2,062.90 -0.81
Alembic Pharma 806.70 -0.99
Wockhardt 1,443.90 -0.99
Orchid Pharma 744.65 -1.64
Mankind Pharma 2,223.90 -1.65
Panacea Biotech 413.40 -4.38

NSE Top Gainers and Losers in Pharma Sector

Top Gainers (NSE):

  • Natco Pharma: +1.24%
  • Dr. Reddy’s Laboratories: +0.32%

Top Losers (NSE):

  • Panacea Biotech: -4.38%
  • Mankind Pharma: -1.65%
  • Orchid Pharma: -1.64%

The pharma sector underperformed the broader market slightly on this day, with limited positive movements. Prices are subject to change as trading continues.

Note: Data is based on snapshot as of around 10:20 AM IST on January 9, 2026. Stock markets are volatile, and investors should conduct their own research.

TOPICS: Pharma